Patients , stratified by disease measurability and participating site , were randomly assigned ( @:@ ) to receive capecitabine @mg/m ( @ ) twice daily for @ days and cisplatin @ mg/m ( @ ) on day @ every @ weeks plus either simvastatin @ mg or placebo , once daily .